Bank of America’s Summit Therapeutics SMMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12M | Buy |
566,147
+196,925
| +53% | +$4.19M | ﹤0.01% | 2626 |
|
|
2025
Q1 | $7.12M | Sell |
369,222
-62,346
| -14% | -$1.2M | ﹤0.01% | 2945 |
|
|
2024
Q4 | $7.7M | Buy |
431,568
+40,908
| +10% | +$730K | ﹤0.01% | 2709 |
|
|
2024
Q3 | $8.56M | Buy |
390,660
+49,513
| +15% | +$1.08M | ﹤0.01% | 2748 |
|
|
2024
Q2 | $2.66M | Sell |
341,147
-49,196
| -13% | -$384K | ﹤0.01% | 3572 |
|
|
2024
Q1 | $1.62M | Buy |
390,343
+268,051
| +219% | +$1.11M | ﹤0.01% | 3859 |
|
|
2023
Q4 | $319K | Buy |
122,292
+58,240
| +91% | +$152K | ﹤0.01% | 4903 |
|
|
2023
Q3 | $120K | Buy |
64,052
+54,476
| +569% | +$102K | ﹤0.01% | 5298 |
|
|
2023
Q2 | $24K | Sell |
9,576
-6,750
| -41% | -$16.9K | ﹤0.01% | 5797 |
|
|
2023
Q1 | $28.6K | Buy |
16,326
+7,374
| +82% | +$12.9K | ﹤0.01% | 5844 |
|
|
2022
Q4 | $38K | Buy |
8,952
+7,268
| +432% | +$30.9K | ﹤0.01% | 5784 |
|
|
2022
Q3 | $2K | Buy |
1,684
+1,478
| +717% | +$1.76K | ﹤0.01% | 6700 |
|
|
2022
Q2 | $0 | Sell |
206
-9,588
| -98% | – | ﹤0.01% | 7366 |
|
|
2022
Q1 | $24K | Sell |
9,794
-9,517
| -49% | -$23.3K | ﹤0.01% | 6653 |
|
|
2021
Q4 | $52K | Buy |
19,311
+7,818
| +68% | +$21.1K | ﹤0.01% | 6349 |
|
|
2021
Q3 | $57K | Buy |
11,493
+2,803
| +32% | +$13.9K | ﹤0.01% | 6101 |
|
|
2021
Q2 | $65K | Sell |
8,690
-33,572
| -79% | -$251K | ﹤0.01% | 5908 |
|
|
2021
Q1 | $248K | Buy |
42,262
+31,872
| +307% | +$187K | ﹤0.01% | 5235 |
|
|
2020
Q4 | $49K | Buy |
10,390
+7,390
| +246% | +$34.9K | ﹤0.01% | 5577 |
|
|
2020
Q3 | $10K | Hold |
3,000
| – | – | ﹤0.01% | 5783 |
|
|
2020
Q2 | $9K | Buy |
+3,000
| New | +$9K | ﹤0.01% | 5863 |
|
|
2018
Q3 | – | Sell |
-100
| Closed | – | – | 6596 |
|
|
2018
Q2 | $0 | Buy |
100
+70
| +233% | – | ﹤0.01% | 6452 |
|
|
2018
Q1 | $0 | Buy |
30
+25
| +500% | – | ﹤0.01% | 6408 |
|
|
2017
Q4 | $0 | Hold |
5
| – | – | ﹤0.01% | 6301 |
|
|
2017
Q3 | $0 | Buy |
+5
| New | – | ﹤0.01% | 6335 |
|